References for "The glutamate hypothesis for schizophrenia"

Published: May, 2009

Buchanan RW, et al. "The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments," American Journal of Psychiatry (Oct. 2007): Vol. 164, No. 10, pp. 1593–602.

Buchanan RW, et al. "Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia," Schizophrenia Bulletin (Sept. 2007): Vol. 33, No. 5, pp. 1120–30.

To continue reading this article, you must log in.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise

New subscriptions to Harvard Health Online are temporarily unavailable. Click the button below to learn about our other subscription offers.

Learn More »